John Eklund

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Chemotherapy dosing in the setting of liver dysfunction.

John Eklund, Steve Trifilio, Mary F. Mulcahy · PubMed · 2005 · 94 citations

Pharmacy, Oncology, Pharmacology +17

A double‐blind randomized vehicle‐controlled clinical trial investigating the effect of ZnPTO dose on the scalp vs. antidandruff efficacy and antimycotic activity

Philip J. Bailey, Caroline Arrowsmith, Kathryn A. Darling et al. · International Journal of Cosmetic Science · 2003 · 36 citations

Pharmacy, Dermatology, Pharmacotherapy +9

A Pilot Study of Denileukin Diftitox (DD) in Combination With High-dose Interleukin-2 (IL-2) for Patients With Metastatic Renal Cell Carcinoma (RCC)

Elizabeth A. Atchison, John Eklund, Brenda Martone et al. · Journal of Immunotherapy · 2010 · 26 citations

Life Sciences, Immunology, Pharmacology +17

Phase II study of mitoxantrone and ketoconazole for hormone‐refractory prostate cancer

John Eklund, Mark Kozloff, Joy Vlamakis et al. · Cancer · 2006 · 22 citations

Medicine, Oncology, Pharmacology +17